GLOBUS MEDICAL INC (GMED) — Analysis Summary
GLOBUS MEDICAL INC (GMED) has a market cap of $11.08B with year-over-year revenue growth of +16.7%. Net margin stands at 18.3%. The stock trades at a P/E ratio of 20.7.
Key Takeaways
- Revenue changed +16.7% year-over-year
- Net margin of 18.3%
- P/E ratio of 20.7
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, GMED posted revenue growth of +16.7% and trades at a P/E of 20.7.
GLOBUS MEDICAL INC (GMED)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
6,000
Headquarters
AUDUBON, PA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.